Cala in the news

Discover how Cala is transforming the standard of care for chronic disease.

Latest press

June 10, 2024
Cala TAPS Therapy is Now Covered by Medicare for Essential Tremor Patients, And Company Appoints CEO and President
January 9, 2024
Cala Announces Data from Multiple Clinical Studies Demonstrating Effective Outcomes of Transcutaneous Afferent Patterned Stimulation (TAPS) Therapy in Essential Tremor (ET) Patients
June 14, 2023
Cala Launches The Cala kIQ™ System, Offering Meaningful Tremor Relief for Patients With Essential Tremor and Now Parkinson’s Disease
April 19, 2023
Cala Introduces Next Generation System and Accelerates Leadership in Bioelectronic Medicine
March 23, 2023
Cala TAPS Therapy for Essential Tremor Patients Improves Outcomes in a New Randomized Controlled Trial
October 11, 2022
Cala Receives Pricing from CMS for Cala TAPS Therapy to Expand Medicare Patient Access
September 27, 2022
Real World Evidence of Cala TAPS Therapy Further Supports Long-Term Safety and Efficacy of its Treatment for Essential Tremor
May 18, 2022
Research Confirms Patients with Essential Tremor and Parkinson’s Disease Have Higher Comorbidities and Costs
May 18, 2022
Cala Partners with SK Biopharmaceuticals to Fuel Innovation in Neurology
April 4, 2022
New Research Presented at AAN Demonstrates Burden Associated with Essential Tremor and the Unmet Patient Need
March 28, 2022
Cala Health Expands Leadership Team to Fuel Growth and Continued Innovation
March 1, 2022
Cala Health Is Building Momentum By Expanding Affordable Access for Patients with Essential Tremor
November 16, 2021
Cala Health Raises $77M to Expand Patient Access and Fuel Continued Innovation
September 14, 2021
Cala Trio is a Rising Standard of Care for the Treatment of Essential Tremor through Clinical Research and Industry Guidelines
June 17, 2021
Cala Health and University of California, San Francisco Announce Partnership to Develop Next-Generation, Smart Neuromodulation Therapies
June 17, 2021
Cala Health Announces Expansion of Executive Team with Steve Higa and Greg Schulte
May 20, 2021
Cala Health Reports New Data Presented at ISPOR, Highlighting Essential Tremor (ET)-Related Comorbidities and Economic Burden
April 15, 2021
Cala Health Reports New Data Demonstrating How Cala Trio™ Enables a More Frequent Assessment of Hand Tremor Compared with In-Person Assessments in Patients with Essential Tremor and Supports Feasibility of Telemedicine Approaches for Essential Tremor Management
November 16, 2020
Cala Health Reports New Data Demonstrating Increasing Prevalence of Essential Tremor (ET) and High Rates of Depression and Anxiety in Patients with ET
October 22, 2020
Cala Health Receives FDA Breakthrough Device Designation for Cala Trio™ Therapy to Treat Action Tremors in Parkinson’s Disease
September 14, 2020
First Real-World Evidence Demonstrates Cala Trio’s Effectiveness in Essential Tremor with Individually Calibrated, Non-Invasive Stimulation
August 17, 2020
Cala Health Announces Continued Growth and Momentum with Clinical, Product Development, and Management Milestones to Support Cala Trio Therapy for the Treatment of Essential Tremor
September 22, 2019
Cala Health Announces Positive Topline Data from Landmark PROSPECT Study for Essential Tremor (ET)
September 3, 2019
Cala Health Names Veteran Leader Renee Ryan as Chief Executive Officer
June 12, 2019
Researcher Developing Nerve Stimulation Device
May 20, 2019
Cala Health Raises $50 Million Series C Funding
March 11, 2019
Cala Health Licenses Innovative Technology from Partners Healthcare to Develop and Deliver Novel Therapies for Patients with Chronic Disease
February 20, 2019
Cala Health participates in Industry and Academic Forum resulting in the Initial Guiding Principles on Ethics in Digital Health
December 16, 2018
Cala Health Enrolls First Patients in Landmark PROSPECT Study for Essential Tremor
April 25, 2018
Cala Health Receives FDA Clearance for Cala ONE, A Neuroperipheral Therapy for Essential Tremor
April 16, 2018
Noninvasive Neuromodulation in Essential Tremor Demonstrates Relief in a Sham-Controlled Pilot Trial
November 7, 2017
Exponential Medicine 2017: Delivering Electricity as Medicine
November 1, 2017
Cala Health’s CEO Kate Rosenbluth selected as a Hive Innovator for 2017 by TEDMED

Media kit